Dr. Melissa Sherman is the CEO of MOBILion Systems Inc., a life science tools company accelerating biotherapeutic drug development and multiomic biomarker discovery with technology licensed from Pacific Northwest National Laboratory in Richland, Washington. She is a passionate business builder with public and private company leadership experience in a wide range of industries including fashion apparel, consumer products, and regenerative medicine. Dr. Sherman achieved successful exits of two companies prior to joining IP Group, an early-stage technology investment firm. At IP Group, Dr. Sherman wrote the initial investment thesis for MOBILion and believed in the opportunity so much she became the founding CEO and raised $54M to achieve commercial launch.